JPM23, Day 3: FDA's Califf weighs in on accelerated approvals, AbbVie CEO touts Humira defense
11th January 2023 Uncategorised 0 JPM23, Day 3: FDA’s Califf weighs in on accelerated approvals, AbbVie CEO touts Humira defense
esagonowsky
Wed, 01/11/2023 – 11:02
More: JPM23, Day 3: FDA's Califf weighs in on accelerated approvals, AbbVie CEO touts Humira defense
Source: fierce
